Miller Joseph M 4/A
4/A · Aurinia Pharmaceuticals Inc. · Filed Feb 22, 2024
Insider Transaction Report
Form 4/AAmended
Miller Joseph M
Chief Financial Officer
Transactions
- Sale
Common Stock
2023-03-02$8.78/sh−11,398$100,074→ 331,112 total
Footnotes (1)
- [F1]Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs.